This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
29 Mar 2016  |  Global  |  Market Research
Top 50 Emerging Technologies: Growth Opportunities of Strategic Imperative
Multi-billion dollar technologies ready to propel industries and transform our world
Research Overview The Top 50 Emerging Technologies research is a comprehensive analysis of the most promising and disruptive technologies poised to impact our world in the next few years. It highlights and offers strategic guidance and actionable ideas on the hottest 50 technologies that pack maximum potential to fuel global innovation; spawn in...
$7,500.00 -
18 Mar 2016  |  North America  |  Market Research
Vital Signs - Stem Cell Therapy in Ischemic Stroke Recovery
Additional Clinical Trials Critical to Building on Early Promise
As indicated by the World Health Organization, stroke is the second-leading cause of death for people over the age of 60 and is the fifth-leading cause of death for those between the ages of 15 and 59. The incidence of stroke is expected to increase by 25% over the next 20 years. Over 40% of ischemic stroke victims have permanent symptoms and only ...
$450.00 -
18 Mar 2016  |  North America  |  Market Research
Vital Signs - Drug Development Focus on Genetically Modified Swine
Modified Swine Hold out Promise of Improving Pre-Clinical Efficacy, Lowering Multi-billion Dollar Drug and Device Development Costs
The US pharmaceutical industry spends approximately $100 billion annually to develop new pharmaceutical drugs and medical devices. Today, a new drug takes approximately 15 years and over $1 billion to bring to market. Product development costs could be greatly reduced by using animal models that more closely resemble humans in their disease states ...
$450.00 -
05 Jan 2016  |  Global  |  Market Research
Vital Signs - Advances in Cancer Treatment, Clampdown on Specialty Pharmacies and Strategy Revamp for Sequencing Provider, An Analysis
Liquid Biopsy Test for Prostate Cancer and Non-small Cell Lung Cancer Treatment Show Promise
This issue of Vital Signs discusses MDxHealth's launch of the SelectMDx Liquid Biopsy Test in Europe, the FDA's approval of a new treatment for non-small cell lung cancer with EGFR mutations, the clamp down on specialty pharmacies by US drug benefit managers, and BGI's strategy redirection for Complete Genomics.
$450.00 -
20 Nov 2012  |  North America  |  Market Research
The U.S. Health Information Exchange Market
A Comprehensive Guide to Market Dynamics, Technology Vendors, and Future Trends
This study provides a roadmap for understanding health information exchange. We provide an in-depth overview of the technical aspects of health information exchange (HIE), review major government initiatives driving health information exchange efforts across the U.S., define and describe the major market segments and subsegments, and look at rece...
$4,950.00 -
27 Sep 2012  |  Europe  |  Market Research
European Alzheimers Disease Medication Market
Launch of Disease-modifying Drugs expected to Boost Market Growth
The key objective of this research service is to study the European Alzheimers disease medication market based on the three major classes of drugs namely acetylcholinesterase inhibitors, NMDA receptor antagonists and new mechanism/ disease modifying drugs and identify the key current and future trends shaping these market segments. It also aims...
$4,950.00 -
31 Aug 2012  |  Asia Pacific  |  Market Research
Strategic Analysis of Contract Research and Manufacturing Services Market in India
Presenting Opportunities for Market Share Gain
This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as ...
$4,950.00 -
15 May 2012  |  North America  |  Market Research
Mölnlycke Health Care—Company Profile
This market insight provides an overview of Mölnlycke Health Care. The Mölnlycke company was established in 1849 by G.F. Henning as primarily a textile manufacturer. In 1997, Mölnlycke Health Care came in to existence when Nordic Capital acquired the medical devices segment of SCA. The company is currently owned by Investor AB and has seen stea...
$1,500.00